Biotech Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Alzheimer’s Disease August 5, 2024
Biotech CureLab Oncology Files Patent Application for Groundbreaking Wound-Healing Therapy June 27, 2024
Biotech Resolution Therapeutics Receives MHRA Approval to Commence Phase I/II EMERALD Study for Lead Candidate RTX001 June 27, 2024
Biotech Proteomics Market to Reach $161.9 billion, Globally, by 2035 at 14.2% CAGR: Allied Market Research June 11, 2024
Biotech IFF to Unveil Breakthrough Alginate Technologies for Biomedical Innovation at WBC and TERMIS May 27, 2024
Biotech 21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally May 6, 2024